The FDA removed two monoclonal antibody therapies from the list of COVID-19 treatments due to their ineffectiveness against the omicron variant, the agency said Jan. 24.
Read the full post on Becker's Hospital Review - Healthcare News
FDA limits use of two COVID-19 antibody treatments due to omicron
